SS

Sameer Shrivastava

Active Director Director DIN 05195141
DIN 05195141 First appointment Feb 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 4 historical roles
Total affiliations 8 Since Feb 2012
Shareholding value •••• Premium profile

About Sameer Shrivastava

Data last updated:

Sameer Shrivastava is a Director at Jivdhara Pharma Private Limited (since 2025), Director at Indrus Biosystems Production Private Limited (since 2025) and Designated Partner at Aventus Biotech Llp (since 2024), and holds 1 more current directorship. The companies operate in Pharma and Healthcare. The largest current company by reported revenue is Jivdhara Pharma Private Limited at ₹17.1 Lakh (FY 2025). Earlier, Sameer Shrivastava was an Additional Director at Bbr (Fine Chemicals) Private Limited (from 2018) and Designated Partner at Maplein Crops Limited Liability Partnership (from 2016) and 2 more.

DIN 05195141
Primary Designation Director
Industry Pharma
First Appointment 07 Feb 2012
Oldest Company Age 14 yrs
Largest company Jivdhara Pharma Private Limited · ₹17.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jivdhara Pharma Private Limited U24230MP2021PTC056656
Director05 Sep 20252021₹17.1 Lakh (FY 2025)Active
Director25 Feb 20252025Active
Designated Partner07 Apr 20242024Active
Director07 Feb 20122011Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bbr (Fine Chemicals) Private Limited U24232KA2013PTC070091
Additional Director05 May 20182013Strike Off
Designated Partner29 Apr 20162016Strike Off
Designated Partner15 Jan 20162016Strike Off
Designated Partner15 Jan 20162016Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bbr (Fine Chemicals) Private Limited
Rowtech Formulations India Private Limited
Maplein Crops Limited Liability Partnership
Maplein Biotic Limited Liability Partnership
Premium access

Shareholding and investment profile for Sameer Shrivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sameer Shrivastava

Sameer Shrivastava currently holds 4 directorships: Jivdhara Pharma Private Limited (Director, since 05 Sep 2025, revenue ₹17.1 Lakh (FY 2025)); Indrus Biosystems Production Private Limited (Director, since 25 Feb 2025); Aventus Biotech Llp (Designated Partner, since 07 Apr 2024); Rowtech Formulations India Private Limited (Director, since 07 Feb 2012).

Sameer Shrivastava was first appointed on 07 Feb 2012 as Director at Rowtech Formulations India Private Limited. The most recent appointment on record is 05 Sep 2025 at Jivdhara Pharma Private Limited.

Sameer Shrivastava held 4 earlier board appointments: Bbr (Fine Chemicals) Private Limited (Additional Director, from 05 May 2018); Maplein Crops Limited Liability Partnership (Designated Partner, from 29 Apr 2016); Maplein Biotic Limited Liability Partnership (Designated Partner, from 15 Jan 2016); Maplein Distilleries Limited Liability Partnership (Designated Partner, from 15 Jan 2016).

The current boards of Sameer Shrivastava's companies include Pramod Srivastava (Jivdhara Pharma Private Limited), Salil Shrivastava (Jivdhara Pharma Private Limited), Srivastava Neera (Jivdhara Pharma Private Limited), Jitendra Tiwari (Indrus Biosystems Production Private Limited), Shailendra Tiwari (Indrus Biosystems Production Private Limited), Pravesh Jain (Aventus Biotech Llp), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available